Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028860

Chief Financial Officer gave up 1,480 shares (to pay taxes)

  • Chief Financial Officer acquired 5,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2018-05-07 Option exercise +5,200 162,065 D: show line 1 in the form
Ruffo Frank Chief Financial Officer 2018-05-07 Shares withheld for taxes −1,480 $18.10 $26,788 160,585 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2018-05-07 Option exercise · Restricted Stock Units −5,200 3,900 D: show line 3 in the form
Loading xslF345X03/doc4.xml…